Pacemaker endocarditis in patients with prosthetic valve replacements: case trilogy and literature review

Shona M M Jenkins1, Nathaniel M Hawkins, Kerry J Hogg

  • 1Department of Cardiology, Stobhill Hospital, Glasgow, UK. shonajenkins@hotmail.com

Insights

Managing infective endocarditis in patients with pacemakers and prosthetic valves is challenging due to a lack of clear guidelines. Complete pacemaker system extraction is crucial, but optimal timing for this and reimplantation remains controversial.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Device Management

Background:

  • Infective endocarditis (IE) poses significant risks in patients with cardiovascular implantable electronic devices (CIEDs) and prosthetic valves.
  • Current management guidelines for CIED-related IE are limited and often contradictory.
  • The combined presence of a permanent pacemaker system and a prosthetic valve complicates IE treatment strategies.

Observation:

  • A case trilogy and literature review were conducted to evaluate the management of IE in patients with both permanent pacemaker systems and prosthetic valves.
  • Physicians face considerable challenges in determining the optimal treatment approach for this complex patient population.
  • Complete extraction of the infected pacemaker system is identified as an essential component of treatment.

Findings:

  • The optimal timing for pacemaker system extraction, duration of antibiotic therapy, and timing of reimplantation are subjects of ongoing debate and lack consensus.
  • The presence of a prosthetic valve significantly exacerbates the management dilemmas associated with pacemaker system IE.
  • Existing recommendations for pacemaker IE alone are insufficient and conflicting, further complicating clinical decision-making.

Implications:

  • There is a critical need for evidence-based guidelines to manage infective endocarditis in patients with both permanent pacemaker systems and prosthetic valves.
  • Further research is required to establish optimal protocols for device extraction, antibiotic treatment duration, and device reimplantation in this high-risk group.
  • Addressing these management challenges is crucial for improving patient outcomes and reducing morbidity and mortality associated with complex IE cases.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.